The tweet was deleted by the author.
But we saved everything 🙂.
Isomorphic Labs has announced $5 billion in funding aimed at accelerating its efforts to transform drug design using artificial intelligence.
Demis Hassabis said the new capital will support the company’s mission to radically reduce the time and cost required to discover new medicines by reimagining drug design from first principles with AI.
View post on X Loading...